Skip to content
Trial Eligibility
Menu

Accelerated rTMS vs. Sham for Stroke Apathy

NCT07113067

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Apathy is a common set of symptoms seen in many people following a stroke. Apathy occurs when a person has lost motivation, becomes withdrawn, and stops doing things that used to be important to them. Apathy has a large negative impact on a person's quality of life, and can also have a large impact the people who take care of them. There are currently no FDA-approved treatments to help with apathy, and other services like therapy may be difficult to access for people who have had a stroke.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Apathy
  • Stroke
  • Stroke Sequelae
  • Stroke/Brain Attack
  • Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic)
  • Motivation
  • Abulia

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1/2
Ages
40 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Medical University of South Carolina
Last updated on ClinicalTrials.gov
July 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

South Carolina · 1

  • Medical University of South Carolina Brain Stimulation Lab · Charleston, SC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.